Livongo Files for IPO With Quick Revenue Growth, Growing Losses — Crunchbase (June 28, 2019)

Summary

Crunchbase article by Alex Wilhelm, dated June 28, 2019, on healthtech startup Livongo filing to go public. It says Livongo, founded in 2014, raised $235 million as a private company, including a $105 million Series D led by General Catalyst and Kinnevik AB, and sells to 679 clients and 164,000 members. It reports that revenue grew from $30.9 million in 2017 to $68.4 million in 2018, while net loss rose from $16.9 million to $33.4 million. For the first three months of 2019 it gives revenue of $32.1 million and a $15.0 million net loss, with cash of $55.0 million at the end of Q1 2019.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

Venture

HealthTech Startup Livongo Files For IPO With Quick Revenue Growth, Growing Losses

Alex Wilhelm

June 28, 2019

Alex Wilhelm alex

As The RealReal begins to trade , another technology IPO is coming into focus. Today, healthtech startup Livongo filed to go public with quick revenue growth, expanding losses, and a story outlining how it intends to replicate early success across more clients, and more illnesses.

Subscribe to the Crunchbase Daily

Livongo, founded in 2014 and based in Mountain View, raised $235 million during its life as a private company. Most recently, the firm raised a $105 million Series D led by General Catalyst and Kinnevik AB . Notably, both General Catalyst and Kinnevik co-led the firm’s Series C , and the former firm led its Series A . General Catalyst owns around a quarter of the company according to its S-1 filing.

Livongo claims to want to “empower people with chronic conditions to live better and healthier lives.” As far as corporate goals go, that’s not a bad approach to making money. Its model works by providing data collection tools (blood sugar testing devices for people with diabetes, for example) to users, coupled to a platform that tracks their personal data (and its progress or regression) and provides support.

Bringing actionable data and support to chronic illness sufferers is a good idea. Livongo has expanded from the diabetes market to other chronic conditions including hypertension and “prediabetes.” The company is also bringing its tech to bear on weight control, among other health issues.

As you can imagine, Livongo sells to large companies who roll its service out to 679 “clients” and 164,000 “members,” according to the company. In the first quarter of 2019, the company claims it added 50,000 of its members. That’s a lot for a single, three-month period given its preceding customer base.

How did that accretion of new users translate to growth in dollar terms? Let’s explore.

The Numbers

As an initial point of reference, Livongo sells its services to customers on a recurring, often multi-year contract basis. As such, we’re dealing with a SaaS-styled company, even though it deals with health issues and not, say, enterprise software.

To understand the company’s growth, let’s compare two time periods: its most recent set of full-year results, and its most-recent quarterly performance.

In yearly terms, Livongo grew from $30.9 million in revenue in 2017 to $68.4 million in 2018. That pace of growth, clocking in at over 100 percent, is the sort of expansion that investors (private and public alike) love to see. Its losses tracked higher at roughly the same percentage growth rate, rising from $16.9 million on a net basis to $33.4 million in the next year.

The company’s more recent performance is similarly sharp. In the first three months of 2018, Livongo posted revenue of $12.5 million, leading to a $4.2 million net loss. In the first three months of 2019, in contrast, Livongo generated revenue of $32.1 million, prompting a $15.0 million net loss. Again, each figure rising quickly as the firm ramps its sales and marketing, and general and administrative spending as its top line explodes.

Inside the headline numbers, the cost of Livongo’s growth is clearer. Observe the following chart tracking its cash consumption:

Translating, the company burned nearly as much cash across its operating and investing activities in the first quarter of 2019 than it did in all of 2018. So, Livongo is growing quickly, but at high expense. Investors likely won’t care given that its losses are merely tracking its revenue north as a manageable percentage, but the company’s cash position of $55.0 million at the end of Q1 2019 implies that it is going public now to raise capital to pay its bills.

Raising money in an IPO needed for operations is no sin, even if it feels retro in the era of Slack’s direct listing . But, Livongo is a company with a working model and a growth that many companies would kill for. All that’s left here is to figure out what the firm is worth, and get it out the door.

Illustration: Li-Anne Dias .

Tags IPO livongo therealreal

Stay up to date with recent funding rounds, acquisitions, and more with the
 Crunchbase Daily.

You may also like

Artificial intelligence • M&A • Startups • Venture

SpaceX Acquires AI Coding Tool Cursor For $60B In Year’s Largest Startup M&A Deal

Marlize van Romburgh

June 16, 2026

The acquisition of Cursor gives SpaceX a foothold into the enterprise software development market, where AI-assisted coding has taken off and led...

Artificial intelligence • Clean tech and energy • Health, Wellness & Biotech • Manufacturing • Robotics • SaaS • Seed funding • Semiconductors and 5G • Startups • Venture

Silicon Is Back: Playground Global’s Decade-Long Bet On Hardware, Energy And Deep Tech Looks Prescient

Gené Teare

June 16, 2026

In the decade-plus since Playground Global's founding, it has built its investment thesis around the idea that breakthroughs in science and...

Artificial intelligence • SaaS • Startups • Venture

Rewriting Your Pitch: SaaS Isn’t Dead, But The Playbook For Founders Is Changing

Guest Author

June 15, 2026

Because AI and LLMs are reshaping the traditional SaaS model, founders are forced to focus less on software alone and more on delivering measurable...

Artificial intelligence • IPO • Liquidity • Regional • Startups • Venture

The AI Startup Funding Boom Is Not A Global Phenomenon

Joanna Glasner

June 15, 2026

So far in 2026, U.S. companies have pulled in nearly 80% of global seed- through growth-stage financing, per Crunchbase data. That’s a sharp...

File and source

File

crunchbase-livongo-ipo-funding-2019.html

Size

160,133 bytes

SHA-256

0b221b9bfb69036f0a77ee57e02c6d66cdc5ae88eac2245d15c1908f5c11c0fd

Our copy

crunchbase-livongo-ipo-funding-2019.html

Original

news.crunchbase.com